William Blair & Company
HQL

William Blair & Company’s abrdn Life Sciences Investors HQL Stock Holding History

William Blair & Company’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-56,022
Closed -$1.14M – 1722
2018
Q3 		$1.14M Hold
56,022
– – 0.01% 700
2018
Q2 		$1.05M Buy
+56,022
New +$1.05M 0.01% 711
2017
Q4 		– Sell
-55,987
Closed -$1.2M – 1401
2017
Q3 		$1.2M Buy
+55,987
New +$1.19M 0.01% 678

Other funds holding HQL

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

William Blair & Company's HQL Position: Q4 2018 in Review

William Blair & Company sold out of abrdn Life Sciences Investors (HQL) in Q4 2018, closing a stake of 56,022 shares — an estimated $1.14M sold.

William Blair & Company first reported a position in HQL in Q3 2017 and held it in 3 quarters. The position peaked at $1.2M in Q3 2017. 59 funds tracked by Wall St. Rank hold HQL as of Q4 2018.

  • William Blair & Company reported no remaining abrdn Life Sciences Investors position as of Q4 2018 after selling out during the quarter.
  • William Blair & Company sold 56,022 abrdn Life Sciences Investors shares in Q4 2018, an estimated $1.14M.
  • William Blair & Company first reported a position in abrdn Life Sciences Investors in Q3 2017 and held it in 3 quarters.
  • William Blair & Company's abrdn Life Sciences Investors position peaked at $1.2M in Q3 2017.
  • 59 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2018.

Based on William Blair & Company's 13F filing for Q4 2018, filed 14 Feb 2019.